NIKI ▼ -1.8% - Niki BioSolutions, Inc.
$NIKI - Niki BioSolutions Accelerates Its Alzheimer’s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics
Niki BioSolutions announced a strategic partnership with Fios Genomics to advance its Alzheimer's disease testing pipeline through bioinformatics and statistical analysis capabilities, though the stock declined 1.8% today despite the pipeline acceleration initiative.
14-SEP-2026 08:31 AM ET
Share this post
More filings for $NIKI
View full $NIKI filing history →💬 Comments
Loading comments…
Leave a comment
